A detailed history of Kestra Private Wealth Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 1,440 shares of BIIB stock, worth $210,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,440
Previous 3,392 57.55%
Holding current value
$210,916
Previous $786,000 64.5%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $369,064 - $462,233
-1,952 Reduced 57.55%
1,440 $279,000
Q2 2024

Aug 12, 2024

SELL
$190.52 - $236.72 $390,947 - $485,749
-2,052 Reduced 37.69%
3,392 $786,000
Q1 2024

May 02, 2024

BUY
$212.02 - $267.71 $38,587 - $48,723
182 Added 3.46%
5,444 $1.17 Million
Q4 2023

Feb 05, 2024

BUY
$222.59 - $267.94 $1.17 Million - $1.41 Million
5,262 New
5,262 $1.36 Million
Q2 2023

Aug 08, 2023

BUY
$275.25 - $318.06 $209,465 - $242,043
761 New
761 $216,000
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $163,344 - $225,237
839 New
839 $224,000
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $219,234 - $260,710
-1,169 Closed
0 $0
Q1 2022

May 26, 2022

SELL
$193.77 - $244.14 $1,356 - $1,708
-7 Reduced 0.6%
1,169 $246,000
Q4 2021

Jan 21, 2022

BUY
$223.92 - $287.77 $7,389 - $9,496
33 Added 2.89%
1,176 $282,000
Q3 2021

Oct 21, 2021

SELL
$282.99 - $369.05 $178,849 - $233,239
-632 Reduced 35.61%
1,143 $323,000
Q2 2021

Jul 30, 2021

SELL
$259.0 - $414.71 $135,198 - $216,478
-522 Reduced 22.73%
1,775 $614,000
Q1 2021

May 11, 2021

SELL
$242.95 - $284.63 $8,017 - $9,392
-33 Reduced 1.42%
2,297 $642,000
Q4 2020

Jan 21, 2021

SELL
$236.26 - $355.63 $190,425 - $286,637
-806 Reduced 25.7%
2,330 $568 Million
Q3 2020

Nov 09, 2020

BUY
$264.77 - $305.71 $830,318 - $958,706
3,136 New
3,136 $889,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.